MC & JS

Quote
anonymous said:
There’s so much that’s wrong with this, I don’t know where to start.

-they sell glaucoma products, but have zero presence within the OD space? Ok...

-novartis bought the drug. Not the people. If you think they bought the people even when their own reps sell in the same space, you’re crazy. We as a work force was the price to get the drug.

-the number of doctors who have “beef” with novartis over buying Alcon is so minuscule, it’s a stupid argument to use.
Click to expand...
Thank you! Finally someone who gets it. These people who believe this pie in the sky pipe dream are in for a rude awakening!
 




































anonymous said:
Thank you! Finally someone who gets it. These people who believe this pie in the sky pipe dream are in for a rude awakening!
Click to expand...

Again, They dont want to throw products in with the glaucoma bag. Market potential is too high for Xiidra. This with an already depleted sales force means everyone is not gone. This is basically what they've been saying. I don't see any changes in 2019. All PHARMA is a year to year gig these days.

If you think you are laid off in 2019 you are a dope.
 


















anonymous said:
Again, They dont want to throw products in with the glaucoma bag. Market potential is too high for Xiidra. This with an already depleted sales force means everyone is not gone. This is basically what they've been saying. I don't see any changes in 2019. All PHARMA is a year to year gig these days.

If you think you are laid off in 2019 you are a dope.
Click to expand...

Dear god.

You have absolutely no idea what you’re talking about. The kool-aid must be good!
 


















anonymous said:
Again, They dont want to throw products in with the glaucoma bag. Market potential is too high for Xiidra. This with an already depleted sales force means everyone is not gone. This is basically what they've been saying. I don't see any changes in 2019. All PHARMA is a year to year gig these days.

If you think you are laid off in 2019 you are a dope.
Click to expand...
Spot On, my friend!!
 






anonymous said:
Again, They dont want to throw products in with the glaucoma bag. Market potential is too high for Xiidra. This with an already depleted sales force means everyone is not gone. This is basically what they've been saying. I don't see any changes in 2019. All PHARMA is a year to year gig these days.

If you think you are laid off in 2019 you are a dope.
Click to expand...

What are you talking about....Yes Xiidra will be thrown in the glaucoma bag. May not seem immediate but certainly sales team will be promoting more than one area in ophthalmics
 






anonymous said:
What are you talking about....Yes Xiidra will be thrown in the glaucoma bag. May not seem immediate but certainly sales team will be promoting more than one area in ophthalmics
Click to expand...
Well its not like weve seen a company that promotes glaucoma and dry eye together in the same bag......not even one that xiidra competes against. It would be crazy to assume that could work :x
 












anonymous said:
Again, You are missing the big picture. Keep your sales rep mentality and negativity and enjoy your misery. I's not product per product for sales force distribution. Its evaluated market potential. Its been made clear to you. If you cant process it then please go get a new job. We can only say it so many ways for you to understand.

They see Xiidra bringing in an additional 1 billion dollars in annual sales at some point. Sorry it doesnt go into a big with 3 other products with a 40% weighting. NVS also expects product launches so they are trying to keep a dug in sales team make it stronger for when they launch the new products that will go to MD and OD They will not want to hire all new reps at that time They want to establish a strong presence for now and the future. You may not believe it but that's what they said. It makes pig picture sense. If those products dont come or get scrapped then you can see a major downsizing. Would it make more sense if I write it in crayon for you?

Now cook a burger, pop a beer and be happy you aren't part of Shikedacom, a company that didnt want us in the first place.
Click to expand...
I so appreciate this post TY.
 






Advice to OBU reps: When the customer knows your name, the relationship BEGINS—but if you want trust and respect you have to move further up the relationship pyramid. Good Selling!!
 






Again, short sited people. They don't want to sacrifice share of voice. Thats the model. There will be changes im sure but dont count on a major layoff anytime soon

If you think your going have a 4 product bag trying to service cornea specials and glaucoma specialists and OD's and general ophth. your crazy there will be overlaps for sure but they wont sacrifice the billion plus market potential. Could it be Xiidra and Pazeo sure, but it wont by Xiidra Simbrinza Pazeo Ciprodex and whatever else they have. still 700 million to go with Xiidra so its not an add to the bag.

anonymous said:
Well its not like weve seen a company that promotes glaucoma and dry eye together in the same bag......not even one that xiidra competes against. It would be crazy to assume that could work :x
Click to expand...
 












Top Bottom
Back
Quote